Patents
Patents for C07J 71 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton is condensed with a heterocyclic ring (3,845)
10/2005
10/05/2005CN1678325A Sapogenin derivatives, their synthesis and use and method based upon the use
10/05/2005CN1221563C Production method of 16-dehydro pregnealcoholketone and its same kind compound
09/2005
09/29/2005US20050215537 Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure
09/29/2005US20050215534 Antiinflammatory agents; asthma; chronic obstructive pulmonary disease; dermatitis; antiallergens; antitumor agents; Aida; antiischemic agents; arrhythmia
09/28/2005EP1580193A2 Eplerenone crystalline form
09/28/2005CN1220698C Triterpene derivatives and remedy for liver diseases
09/28/2005CN1220696C 16 alpha-methyl or ethyl substituted estrogens
09/27/2005US6949533 use in treating asthma, allergy, arthritis and thrombosis
09/22/2005US20050209445 Using solvent extraction to isolate saponins from aquatic plants
09/22/2005US20050209206 Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier
09/21/2005EP1575983A1 17.beta-[alpha-hydroxy]-esters of androstanes as intermediates for the preparation of 17.beta.-fluorinated-androstane esters
09/21/2005CN1219792C Method for synthesizing sechuded chamber saponin
09/09/2005WO2005082392A1 Tumor cell-specific growth inhibitor comprising ashwagandha leaf extract
09/07/2005EP1571153A2 A process for the preparation of drospirenone
09/01/2005US20050192450 starting from 5,6 beta -epoxy-7 beta -hydroxy-15 beta ,16 beta -methylene-3 beta -pivaloyloxy-5 beta -androstan-17-one; oxidation step is carried out by microbiological route using acetic bacteria; high degree of purity
09/01/2005US20050192437 Process for the preparation of 6alpha-fluoro steroids by isomerisation of 6beta-fluorosteroids
09/01/2005CA2761534A1 A process for the preparation of drospirenone
08/2005
08/31/2005CN1216897C Application of tribulus spirosteroid spaonin compound in preparation of antifungal medicine
08/31/2005CN1216861C Crystals of vitamin D derivatives and process for the preparation thereof
08/17/2005CN1215080C Substd. sapogenins and their use
08/10/2005CN1653081A C-17 spirolactonization and 6, 7 oxidation of steroids
08/10/2005CN1651455A Pseudo portulaca oleracea saponin compound, total sapon in and its application in medicine
08/10/2005CN1651454A Preparation method of steroid medicine for treating respiration channel disease and its intermediate
08/10/2005CN1214039C 3-nitrogen-6,7-dioxygen steroids and uses thereof
08/10/2005CN1214038C 9alpha-chloro-6alpha-fluoro-17alpha-16-methyl-17-beta-methoxy carbonyl-androst-1, 4-dienes esterified in position 17 alpha by a cyclic acyl proup
08/03/2005EP1558627A1 Stereospecific reduction of sapogen-3-ones
08/03/2005EP1175433B1 Androgen glycosides and androgenic activity thereof
08/03/2005CN1649891A Improved synthesis of cyproterone acetate
07/2005
07/28/2005US20050165022 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
07/28/2005US20050164997 a 3-oxo-androstancarbothioic acid compound; respiaratory system disorder
07/26/2005US6921757 Conversion of carboxylic acid substituent in a gonane ring, into the methyl ester, or hydrochlorination of a 9-11-epoxy-9-H-cyclopenta(a)phenanthrene compounds
07/21/2005US20050159594 Aldosterone receptor antagonist; comprises 7-methyl hydrogen 4a,5a;9a,11a-diepoxy-17 hydroxy-3-oxo-17a-pregnane-7a,21-dicarboxylate, gamma-lactone as dopant
07/21/2005US20050159484 Medicament
07/20/2005EP1242444B1 Process for preparing 17alpha-acetoxy-11beta- 4-n,n-(dimethylamino)phenyl]-21-methoxy-19-norpregna-4,9-diene-3,20-dione, intermediates useful in the process, and processes for preparing such intermediates
07/20/2005CN1642558A Theraputic methods and uses of sapogenins and their derivatives
07/20/2005CN1640886A Method for producing soap element from yellow ginger
07/14/2005WO2005063790A1 Isolation of tigogenin pentaglycoside from chlorophytum nimonii
07/14/2005WO2005063789A1 Isolation of bivittoside d from sea cucumber and activity thereof
07/14/2005WO2005063777A1 Benzylphosphate and substituted benzylphosphate prodrugs for the treatment of pulmonary inflammation
07/13/2005CN1637017A Crystals of a vitamin D derivative and a method for the preparation thereof
07/13/2005CN1637016A Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11
07/12/2005US6916791 Androgen glycosides useful as contraceptives, for increasing muscle mass, and treatment of a hypogonadal disorder, androgen deficiency, sexual dysfunction and osteoporosis
07/06/2005CN1634973A Philinopside E, a novel antineoplastic compound in pentacta quadrangulasis
07/06/2005CN1634970A Process for preparing notoginsen triterpenes
07/06/2005CN1209112C Smilagenin and anzurogenin-D for treating Alzheimer's disease
07/05/2005CA2118928C Saponin-antigen conjugates and the use thereof
06/2005
06/30/2005WO2005058935A2 Aqueous suspensions of ciclesonide for nebulisation
06/30/2005US20050143365 Structural modification of 19-norprogesterone I: 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
06/30/2005US20050143364 21-Substituted progesterone derivatives as new antiprogestational agents
06/30/2005CA2549038A1 Aqueous suspensions of ciclesonide for nebulisation
06/29/2005EP1548025A2 Sapogenin derivatives and their use in the treatment of cognitive dysfunction
06/29/2005CN1633445A Process to prepare eplerenone
06/22/2005EP1542996A2 Octahydro-2-h-naphtho 1,2-f indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators
06/22/2005CN1629182A Oslasodine hydrochloride preparing process
06/16/2005US20050130948 Therapeutic methods and uses of sapogenins and their derivatives
06/16/2005US20050130947 6alpha, 9alpha-Difluoro-17alpha-((2-furanylcarbonyl)oxy)-11beta-hydroxy-16alpha-methyl-3-oxo-androsta-1,4-diene-17beta-carbothioic acid S-fluoromethyl ester completely dissolved in a liquified hydrofluoroalkane (HFA) gas as propellant; for asthma or chronic obstructive pulmonary disease (COPD)
06/16/2005US20050130944 Method of making and using 7alpha,11beta-dimethyl-17beta-hydroxyestr-4-en-3-one 17-undecanoate
06/16/2005US20050130221 Synthesis for the preparation of compounds for screening as potential tubulin binding agents
06/15/2005EP1251856B1 Method of increasing alertness by administration of a vomeropherin, and vomeropherin-emitting alarm devices
06/15/2005CN1626546A New method for preparing Ciclesonide medication for treating asthma disease
06/09/2005US20050124594 Prophylactic treatment of eyes as having high risk of developing choroidal neovascularisation in macular degerneration by injecting an antiinflammatory steroid, e.g., triamcinolone acetonide, into the vitreous; occult and classic neovascularisation; mixture with antibiotic or angiogenesis inhibitors
06/01/2005CN1621410A Clean production technology for extracting saponin from peltate yam rahizome
05/2005
05/31/2005US6900193 Urogential disorders; antitumor agents; hormone inhibitor
05/18/2005EP1224204B1 Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11
05/18/2005CN1616480A Method for producing dioscin by directly extracting saponin without pollution
05/11/2005CN1613866A Preparation of gynostemma pentaphylla saponin
05/04/2005EP1307471B1 16alpha-methyl or ethyl substituted estrogens
05/04/2005CN1199984C Application method of super critical fluid extracting device in yam saponin production
05/03/2005US6887991 Converting a 7-cyano substituted steroid to the corresponding 7- carboxylic acid substituted steroid, and thereafter converting the 7-carboxylic acid substituted steroid to the corresponding 5,7-lactone substituted steroid
05/03/2005US6887882 Comprises (5bR-(5b-a,6b,12b-a))-5b,6,7,12b,13,14-hexahydro-13 -methyl(1,3)benzodioxolo(5,6c)-1,3-dioxolo(4,5-i)phenanthrid in-6-ol; for use as antiarrhythmic drugs; potassium channel modulators
04/2005
04/28/2005US20050090663 Carbonylation; hydrogenation; epoxidation; alkynylation; for preparation of eplerenone
04/27/2005CN1198622C Steroidal saponins for treating alzheimer's disease and derivatives thereof
04/20/2005EP1523315A1 3-o-[alfa-l-rhamnopyranosyl-(1-2)-alfa-l-rhamnopyranosyl-(1-4)-3beta-d-glucopyranosyl]-25(s)-spirostan-3beta-ol, process for its isolation, and its use as immunomodulator
04/14/2005US20050080063 Process for the production of 16,17-[{cyclohexylmethylen)bis(oxy)]-11,21-dihydroxy-pregna-1,4-dien-3,20-dion or its 21-isobutyrat by transketalisation
04/12/2005US6878699 Taccalonolide microtubule stabilizing agents
04/06/2005EP1299409B1 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group
04/06/2005CN1195743C Dihydro-1, 3, 5-triazine amine derivatives and their therapeutic uses
03/2005
03/31/2005WO2005028495A1 Anti-inflammatory glucocorticoids
03/31/2005US20050070515 Glucocorticosteroids which are hydrolysable in human or animal blood by lactonase enzyme; for treatment of respiratory and gastrointestinal disorders; side effect reduction
03/30/2005EP1517694A1 Plant extracts
03/29/2005CA2100514C 17-spiromethylene steroids
03/17/2005US20050059642 Plant fungicides and bactericides; antibiotic resistant staphylococcus and enterococcus; turf grasses; improved chemical resistance and stability
03/16/2005CN1596241A Method for the preparation of 6alpha-fluoro corticosteroids
03/16/2005CN1193039C Process for synthesis of 2, 4-O-di-alpha-L-pyranorhamnosyl-beta-D-pyranoglucosyldioscin
03/09/2005CN1590401A High selectivity synthesis of 6 alpha fluoro storoid
03/09/2005CN1589858A New use of cimicifuga root and its affective part monomer in treating hepatitis B and its preparation method
03/09/2005CN1192034C Process for producing diels-alder adducts of sterol 5,7-dienes using unsaturated fatty acid catalyst
03/02/2005CN1587274A Processing method and device for extracting saponin from peltate yam by directly separating method
03/01/2005US6861521 Stereoselective transacetalization of steroidal C-22 acetonide
03/01/2005US6861415 Antagonize endogenous progesterone to induce menses or labor, treat endometriosis, dysmenorrhea; endocrine hormone-dependent tumors, and uterine fibroids, inhibit uterine endometrial proliferation and for contraception
02/2005
02/24/2005US20050043284 containing an anti-inflammatory and anti-allergic compound of the androstane series
02/23/2005CN1583784A 17 alpha, 22-dicarboxy furo compound and its use
02/22/2005US6858596 Aqueous suspension of Fluticasone furoate; respiratory tract disorders; asthma, COPD; antiinflammatory, antiallergen; nasal inhaler
02/09/2005EP1505072A2 Eplerenone crystalline form exhiniting enhanced dissolution rate
02/09/2005CN1188425C Novel process for preparing diosgenin
02/08/2005US6852710 Antitumor agents, anticancer agents
02/03/2005WO2004085457A3 17beta-hydroxysteroid dehydrogenase inhibitors
02/03/2005US20050026888 Formulation containing anti-inflammatory androstane derivatives
02/02/2005EP1501858A2 Further syntheses of cyproterone acetate
02/02/2005CN1187368C Carboxylic derivs. of diosgenin and process for preparing same
1 ... 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 ... 39